Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Huvitz Co., Ltd. (065510:KRX), powered by AI.
Huvitz Co., Ltd. is currently trading at ₩7,270. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Huvitz Co., Ltd. on Alpha Lenz.
Huvitz Co., Ltd.'s P/E ratio is -15.9.
“Huvitz Co., Ltd. trades at a P/E of -15.9 (undervalued) with modest ROE of -4.5%.”
Ask for details →Huvitz Co., Ltd. is a renowned leader in the optical technology domain, primarily engaged in the design, development, and manufacturing of precision instruments. The company's products cater to both the medical and optical industries, with a focus on supplying innovative solutions for eye care professionals. Huvitz specializes in manufacturing ophthalmic equipment such as auto refractor keratometers, lensmeters, and digital imaging devices, all vital tools in the assessment and correction of vision issues. In addition, the company extends its technological prowess to the development of dental and medical imaging systems, further broadening its impact across healthcare sectors. Headquartered in South Korea, Huvitz Co., Ltd. holds a significant presence in the global market, supporting eye care specialists, optometrists, and ophthalmologists by providing reliable and advanced diagnostic equipment to ensure efficient patient care. By leveraging cutting-edge optical technologies, Huvitz has cemented its position as a vital contributor to advancements in clinical instrumentation and patient diagnostic services worldwide.
“Huvitz Co., Ltd. trades at a P/E of -15.9 (undervalued) with modest ROE of -4.5%.”
Ask for details →Huvitz Co., Ltd. (ticker: 065510) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 244 employees. Market cap is $79.1B.
The current price is ₩7,270 with a P/E ratio of -15.9x and P/B of 0.75x.
ROE is -4.50% and operating margin is 4.70%. Annual revenue is $118.0B.